Beta-Blockers after Myocardial Infarction — Toward Personalized Management
T
Thomas F. Lüscher
(Royal Brompton Hospital, Guy’s and St. Thomas’ NHS Foundation Trust, London)
F
Florian A. Wenzl
(Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland)
Article Details
Journal
New England Journal of Medicine
Volume / Issue
Vol. 394, Issue 6
Published
February 05, 2026
Pages
599-602
ISSN
0028-4793
Publisher
Massachusetts Medical Society
Journal Info
New England Journal of Medicine
Massachusetts Medical Society
ISSN: 0028-4793 Social Sciences
Authors (2)
T
Thomas F. Lüscher
Royal Brompton Hospital, Guy’s and St. Thomas’ NHS Foundation Trust, London
F
Florian A. Wenzl
Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland
Related Articles from this Journal
Doctor’s Dirty Little Secret — The Cost of Silence
Tara Khan
Aug 2026
10.1056/nejmp2515506
Obstructive Hypertrophic Cardiomyopathy
Julian-Kai Nishizono, Marohito Nakata
Aug 2026
10.1056/nejmicm2603868
T-Cell Engager–Mediated HLA Antibody Depletion before Kidney Transplantation
Martina Schatzl, Katharina A. Mayer et al.
Jul 2026
10.1056/nejmc2603853
Products That Pose Health Risks — Can Litigation Protect Us When Government Fails?
Jerry Avorn
Jul 2026
10.1056/nejmp2604841
Precision Intensification in Metastatic Prostate Cancer
Rana R. McKay
Jul 2026
10.1056/nejme2605582